Titre : Sphingolipides

Sphingolipides : Questions médicales fréquentes

Termes MeSH sélectionnés :

Pilot Projects
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Sphingolipides : Questions médicales les plus fréquentes", "headline": "Sphingolipides : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Sphingolipides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-13", "dateModified": "2025-03-10", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Sphingolipides" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Lipides membranaires", "url": "https://questionsmedicales.fr/mesh/D008563", "about": { "@type": "MedicalCondition", "name": "Lipides membranaires", "code": { "@type": "MedicalCode", "code": "D008563", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Glycosphingolipides", "alternateName": "Glycosphingolipids", "url": "https://questionsmedicales.fr/mesh/D006028", "about": { "@type": "MedicalCondition", "name": "Glycosphingolipides", "code": { "@type": "MedicalCode", "code": "D006028", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Glycosphingolipides acides", "alternateName": "Acidic Glycosphingolipids", "url": "https://questionsmedicales.fr/mesh/D020384", "about": { "@type": "MedicalCondition", "name": "Glycosphingolipides acides", "code": { "@type": "MedicalCode", "code": "D020384", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Gangliosides", "alternateName": "Gangliosides", "url": "https://questionsmedicales.fr/mesh/D005732", "about": { "@type": "MedicalCondition", "name": "Gangliosides", "code": { "@type": "MedicalCode", "code": "D005732", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ganglioside GM1", "alternateName": "G(M1) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005677", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM1", "code": { "@type": "MedicalCode", "code": "D005677", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.390" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM2", "alternateName": "G(M2) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005678", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM2", "code": { "@type": "MedicalCode", "code": "D005678", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.400" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM3", "alternateName": "G(M3) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005679", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM3", "code": { "@type": "MedicalCode", "code": "D005679", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.510" } } } ] }, { "@type": "MedicalWebPage", "name": "Ganglioside GM1", "alternateName": "G(M1) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005677", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM1", "code": { "@type": "MedicalCode", "code": "D005677", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.390" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM2", "alternateName": "G(M2) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005678", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM2", "code": { "@type": "MedicalCode", "code": "D005678", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.400" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM3", "alternateName": "G(M3) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005679", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM3", "code": { "@type": "MedicalCode", "code": "D005679", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.510" } } }, { "@type": "MedicalWebPage", "name": "Sulfoglycosphingolipides", "alternateName": "Sulfoglycosphingolipids", "url": "https://questionsmedicales.fr/mesh/D013433", "about": { "@type": "MedicalCondition", "name": "Sulfoglycosphingolipides", "code": { "@type": "MedicalCode", "code": "D013433", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.837" } } } ] }, { "@type": "MedicalWebPage", "name": "Gangliosides", "alternateName": "Gangliosides", "url": "https://questionsmedicales.fr/mesh/D005732", "about": { "@type": "MedicalCondition", "name": "Gangliosides", "code": { "@type": "MedicalCode", "code": "D005732", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ganglioside GM1", "alternateName": "G(M1) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005677", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM1", "code": { "@type": "MedicalCode", "code": "D005677", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.390" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM2", "alternateName": "G(M2) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005678", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM2", "code": { "@type": "MedicalCode", "code": "D005678", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.400" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM3", "alternateName": "G(M3) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005679", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM3", "code": { "@type": "MedicalCode", "code": "D005679", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.510" } } } ] }, { "@type": "MedicalWebPage", "name": "Ganglioside GM1", "alternateName": "G(M1) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005677", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM1", "code": { "@type": "MedicalCode", "code": "D005677", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.390" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM2", "alternateName": "G(M2) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005678", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM2", "code": { "@type": "MedicalCode", "code": "D005678", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.400" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM3", "alternateName": "G(M3) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005679", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM3", "code": { "@type": "MedicalCode", "code": "D005679", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.510" } } }, { "@type": "MedicalWebPage", "name": "Sulfoglycosphingolipides", "alternateName": "Sulfoglycosphingolipids", "url": "https://questionsmedicales.fr/mesh/D013433", "about": { "@type": "MedicalCondition", "name": "Sulfoglycosphingolipides", "code": { "@type": "MedicalCode", "code": "D013433", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.837" } } }, { "@type": "MedicalWebPage", "name": "Glycosphingolipides neutres", "alternateName": "Neutral Glycosphingolipids", "url": "https://questionsmedicales.fr/mesh/D020383", "about": { "@type": "MedicalCondition", "name": "Glycosphingolipides neutres", "code": { "@type": "MedicalCode", "code": "D020383", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Céramides", "alternateName": "Ceramides", "url": "https://questionsmedicales.fr/mesh/D002518", "about": { "@type": "MedicalCondition", "name": "Céramides", "code": { "@type": "MedicalCode", "code": "D002518", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cérébrosides", "alternateName": "Cerebrosides", "url": "https://questionsmedicales.fr/mesh/D002554", "about": { "@type": "MedicalCondition", "name": "Cérébrosides", "code": { "@type": "MedicalCode", "code": "D002554", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } } ] }, { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } }, { "@type": "MedicalWebPage", "name": "Globosides", "alternateName": "Globosides", "url": "https://questionsmedicales.fr/mesh/D005915", "about": { "@type": "MedicalCondition", "name": "Globosides", "code": { "@type": "MedicalCode", "code": "D005915", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.425" } } }, { "@type": "MedicalWebPage", "name": "Lactosylcéramides", "alternateName": "Lactosylceramides", "url": "https://questionsmedicales.fr/mesh/D007790", "about": { "@type": "MedicalCondition", "name": "Lactosylcéramides", "code": { "@type": "MedicalCode", "code": "D007790", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.612" } } }, { "@type": "MedicalWebPage", "name": "Trihexosylcéramide", "alternateName": "Trihexosylceramides", "url": "https://questionsmedicales.fr/mesh/D014281", "about": { "@type": "MedicalCondition", "name": "Trihexosylcéramide", "code": { "@type": "MedicalCode", "code": "D014281", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.906" } } } ] }, { "@type": "MedicalWebPage", "name": "Cérébrosides", "alternateName": "Cerebrosides", "url": "https://questionsmedicales.fr/mesh/D002554", "about": { "@type": "MedicalCondition", "name": "Cérébrosides", "code": { "@type": "MedicalCode", "code": "D002554", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } } ] }, { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } }, { "@type": "MedicalWebPage", "name": "Globosides", "alternateName": "Globosides", "url": "https://questionsmedicales.fr/mesh/D005915", "about": { "@type": "MedicalCondition", "name": "Globosides", "code": { "@type": "MedicalCode", "code": "D005915", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.425" } } }, { "@type": "MedicalWebPage", "name": "Lactosylcéramides", "alternateName": "Lactosylceramides", "url": "https://questionsmedicales.fr/mesh/D007790", "about": { "@type": "MedicalCondition", "name": "Lactosylcéramides", "code": { "@type": "MedicalCode", "code": "D007790", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.612" } } }, { "@type": "MedicalWebPage", "name": "Trihexosylcéramide", "alternateName": "Trihexosylceramides", "url": "https://questionsmedicales.fr/mesh/D014281", "about": { "@type": "MedicalCondition", "name": "Trihexosylcéramide", "code": { "@type": "MedicalCode", "code": "D014281", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.906" } } }, { "@type": "MedicalWebPage", "name": "Sphingomyéline", "alternateName": "Sphingomyelins", "url": "https://questionsmedicales.fr/mesh/D013109", "about": { "@type": "MedicalCondition", "name": "Sphingomyéline", "code": { "@type": "MedicalCode", "code": "D013109", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.870" } } } ] }, { "@type": "MedicalWebPage", "name": "Céramides", "alternateName": "Ceramides", "url": "https://questionsmedicales.fr/mesh/D002518", "about": { "@type": "MedicalCondition", "name": "Céramides", "code": { "@type": "MedicalCode", "code": "D002518", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cérébrosides", "alternateName": "Cerebrosides", "url": "https://questionsmedicales.fr/mesh/D002554", "about": { "@type": "MedicalCondition", "name": "Cérébrosides", "code": { "@type": "MedicalCode", "code": "D002554", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } } ] }, { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } }, { "@type": "MedicalWebPage", "name": "Globosides", "alternateName": "Globosides", "url": "https://questionsmedicales.fr/mesh/D005915", "about": { "@type": "MedicalCondition", "name": "Globosides", "code": { "@type": "MedicalCode", "code": "D005915", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.425" } } }, { "@type": "MedicalWebPage", "name": "Lactosylcéramides", "alternateName": "Lactosylceramides", "url": "https://questionsmedicales.fr/mesh/D007790", "about": { "@type": "MedicalCondition", "name": "Lactosylcéramides", "code": { "@type": "MedicalCode", "code": "D007790", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.612" } } }, { "@type": "MedicalWebPage", "name": "Trihexosylcéramide", "alternateName": "Trihexosylceramides", "url": "https://questionsmedicales.fr/mesh/D014281", "about": { "@type": "MedicalCondition", "name": "Trihexosylcéramide", "code": { "@type": "MedicalCode", "code": "D014281", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.906" } } } ] }, { "@type": "MedicalWebPage", "name": "Cérébrosides", "alternateName": "Cerebrosides", "url": "https://questionsmedicales.fr/mesh/D002554", "about": { "@type": "MedicalCondition", "name": "Cérébrosides", "code": { "@type": "MedicalCode", "code": "D002554", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } } ] }, { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } }, { "@type": "MedicalWebPage", "name": "Globosides", "alternateName": "Globosides", "url": "https://questionsmedicales.fr/mesh/D005915", "about": { "@type": "MedicalCondition", "name": "Globosides", "code": { "@type": "MedicalCode", "code": "D005915", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.425" } } }, { "@type": "MedicalWebPage", "name": "Lactosylcéramides", "alternateName": "Lactosylceramides", "url": "https://questionsmedicales.fr/mesh/D007790", "about": { "@type": "MedicalCondition", "name": "Lactosylcéramides", "code": { "@type": "MedicalCode", "code": "D007790", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.612" } } }, { "@type": "MedicalWebPage", "name": "Trihexosylcéramide", "alternateName": "Trihexosylceramides", "url": "https://questionsmedicales.fr/mesh/D014281", "about": { "@type": "MedicalCondition", "name": "Trihexosylcéramide", "code": { "@type": "MedicalCode", "code": "D014281", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.906" } } }, { "@type": "MedicalWebPage", "name": "Sphingomyéline", "alternateName": "Sphingomyelins", "url": "https://questionsmedicales.fr/mesh/D013109", "about": { "@type": "MedicalCondition", "name": "Sphingomyéline", "code": { "@type": "MedicalCode", "code": "D013109", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.870" } } }, { "@type": "MedicalWebPage", "name": "Psychosine", "alternateName": "Psychosine", "url": "https://questionsmedicales.fr/mesh/D011609", "about": { "@type": "MedicalCondition", "name": "Psychosine", "code": { "@type": "MedicalCode", "code": "D011609", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.806" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Sphingolipides", "alternateName": "Sphingolipids", "code": { "@type": "MedicalCode", "code": "D013107", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Erich Gulbins", "url": "https://questionsmedicales.fr/author/Erich%20Gulbins", "affiliation": { "@type": "Organization", "name": "Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany." } }, { "@type": "Person", "name": "Giovanni D'Angelo", "url": "https://questionsmedicales.fr/author/Giovanni%20D%27Angelo", "affiliation": { "@type": "Organization", "name": "Interfaculty Institute of Bioengineering, Ecole polytechnique fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland giovanni.dangelo@epfl.ch Christopher.Clarke@stonybrookmedicine.edu lianacsilva@ff.ulisboa.pt." } }, { "@type": "Person", "name": "Anna Kovilakath", "url": "https://questionsmedicales.fr/author/Anna%20Kovilakath", "affiliation": { "@type": "Organization", "name": "Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, United States." } }, { "@type": "Person", "name": "L Ashley Cowart", "url": "https://questionsmedicales.fr/author/L%20Ashley%20Cowart", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States." } }, { "@type": "Person", "name": "Tyrone Dowdy", "url": "https://questionsmedicales.fr/author/Tyrone%20Dowdy", "affiliation": { "@type": "Organization", "name": "Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Service Demand for and Awareness of a Primary Healthcare Pilot Project for People With Disabilities.", "datePublished": "2022-08-01", "url": "https://questionsmedicales.fr/article/35916049", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3346/jkms.2022.37.e241" } }, { "@type": "ScholarlyArticle", "name": "[The KomMent study: a pilot project on structured interprofessional communication in uro-oncology].", "datePublished": "2022-10-07", "url": "https://questionsmedicales.fr/article/36205744", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00120-022-01945-x" } }, { "@type": "ScholarlyArticle", "name": "[Psychiatric-Psychotherapeutic Care in Crisis: Results of the LeiP#Netz Pilot Project].", "datePublished": "2022-11-25", "url": "https://questionsmedicales.fr/article/36427493", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-1902-6326" } }, { "@type": "ScholarlyArticle", "name": "Adaptation of Screening Tools for Social Determinants of Health in Pregnancy: A Pilot Project.", "datePublished": "2023-06-14", "url": "https://questionsmedicales.fr/article/37316688", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10995-023-03732-2" } }, { "@type": "ScholarlyArticle", "name": "Colorectal Cancer Screening Pilot Project in Tehran-Iran, a Feasibility Study.", "datePublished": "2023-03-01", "url": "https://questionsmedicales.fr/article/37543936", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.34172/aim.2023.22" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Lipides", "item": "https://questionsmedicales.fr/mesh/D008055" }, { "@type": "ListItem", "position": 3, "name": "Lipides membranaires", "item": "https://questionsmedicales.fr/mesh/D008563" }, { "@type": "ListItem", "position": 4, "name": "Sphingolipides", "item": "https://questionsmedicales.fr/mesh/D013107" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Sphingolipides - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Sphingolipides", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Sphingolipides", "description": "Comment diagnostiquer une maladie liée aux sphingolipides ?\nQuels tests sont utilisés pour évaluer les sphingolipides ?\nLes symptômes peuvent-ils indiquer un déséquilibre des sphingolipides ?\nQuelle imagerie est utile pour les maladies des sphingolipides ?\nLes antécédents familiaux sont-ils importants pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Pilot+Projects&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Sphingolipides", "description": "Quels sont les symptômes des troubles liés aux sphingolipides ?\nLes troubles digestifs sont-ils associés aux sphingolipides ?\nComment les sphingolipides affectent-ils le système nerveux ?\nLes troubles de la peau sont-ils fréquents avec les sphingolipides ?\nLes symptômes varient-ils selon le type de sphingolipide ?", "url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Pilot+Projects&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Sphingolipides", "description": "Peut-on prévenir les maladies liées aux sphingolipides ?\nLes tests génétiques aident-ils à la prévention ?\nL'éducation sur les sphingolipides est-elle importante ?\nLes habitudes alimentaires influencent-elles la santé des sphingolipides ?\nLes vaccinations peuvent-elles aider à prévenir des complications ?", "url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Pilot+Projects&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Sphingolipides", "description": "Quels traitements existent pour les maladies des sphingolipides ?\nLa diète peut-elle influencer les niveaux de sphingolipides ?\nLes médicaments peuvent-ils réduire les symptômes ?\nY a-t-il des traitements expérimentaux pour ces maladies ?\nLa thérapie génique est-elle une option pour ces maladies ?", "url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Pilot+Projects&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Sphingolipides", "description": "Quelles complications peuvent survenir avec les troubles des sphingolipides ?\nLes troubles respiratoires sont-ils une complication possible ?\nComment les sphingolipides affectent-ils le cœur ?\nLes complications neurologiques sont-elles fréquentes ?\nLes complications peuvent-elles être réversibles ?", "url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Pilot+Projects&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Sphingolipides", "description": "Quels sont les facteurs de risque pour les maladies des sphingolipides ?\nL'âge influence-t-il le risque de troubles des sphingolipides ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nLe mode de vie influence-t-il le risque ?\nLes infections peuvent-elles aggraver les troubles des sphingolipides ?", "url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Pilot+Projects&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une maladie liée aux sphingolipides ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests génétiques, des analyses biochimiques et des biopsies." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les sphingolipides ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des analyses d'urine mesurent les niveaux de sphingolipides." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils indiquer un déséquilibre des sphingolipides ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes neurologiques ou cutanés peuvent signaler un déséquilibre." } }, { "@type": "Question", "name": "Quelle imagerie est utile pour les maladies des sphingolipides ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM et la TDM peuvent aider à visualiser les effets des maladies sur les organes." } }, { "@type": "Question", "name": "Les antécédents familiaux sont-ils importants pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antécédents familiaux peuvent indiquer une prédisposition génétique aux maladies." } }, { "@type": "Question", "name": "Quels sont les symptômes des troubles liés aux sphingolipides ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles neurologiques, des problèmes cutanés et des douleurs." } }, { "@type": "Question", "name": "Les troubles digestifs sont-ils associés aux sphingolipides ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles digestifs peuvent être liés à des anomalies des sphingolipides." } }, { "@type": "Question", "name": "Comment les sphingolipides affectent-ils le système nerveux ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils jouent un rôle dans la myélinisation et la signalisation neuronale, affectant la fonction nerveuse." } }, { "@type": "Question", "name": "Les troubles de la peau sont-ils fréquents avec les sphingolipides ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des affections cutanées comme l'eczéma peuvent être liées à des déséquilibres." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de sphingolipide ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes dépendent du type de sphingolipide impliqué et de l'organe affecté." } }, { "@type": "Question", "name": "Peut-on prévenir les maladies liées aux sphingolipides ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques." } }, { "@type": "Question", "name": "Les tests génétiques aident-ils à la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques peuvent identifier les personnes à risque et guider la prévention." } }, { "@type": "Question", "name": "L'éducation sur les sphingolipides est-elle importante ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, comprendre les sphingolipides aide à reconnaître les symptômes et à agir rapidement." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles la santé des sphingolipides ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée peut soutenir la santé des sphingolipides et prévenir des troubles." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles aider à prévenir des complications ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent prévenir des infections qui aggravent les troubles liés aux sphingolipides." } }, { "@type": "Question", "name": "Quels traitements existent pour les maladies des sphingolipides ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des thérapies enzymatiques, des médicaments et des soins symptomatiques." } }, { "@type": "Question", "name": "La diète peut-elle influencer les niveaux de sphingolipides ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en acides gras essentiels peut aider à réguler les sphingolipides." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils réduire les symptômes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent atténuer les symptômes et améliorer la qualité de vie." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux pour ces maladies ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des essais cliniques explorent de nouvelles thérapies pour les troubles des sphingolipides." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option pour ces maladies ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche pour traiter certaines maladies liées aux sphingolipides." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les troubles des sphingolipides ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles neurologiques graves, des infections et des défaillances organiques." } }, { "@type": "Question", "name": "Les troubles respiratoires sont-ils une complication possible ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles des sphingolipides peuvent entraîner des complications respiratoires." } }, { "@type": "Question", "name": "Comment les sphingolipides affectent-ils le cœur ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des déséquilibres peuvent contribuer à des maladies cardiovasculaires et à des arythmies." } }, { "@type": "Question", "name": "Les complications neurologiques sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications comme la démence ou des troubles moteurs peuvent survenir." } }, { "@type": "Question", "name": "Les complications peuvent-elles être réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les maladies des sphingolipides ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des mutations génétiques et des déséquilibres nutritionnels." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de troubles des sphingolipides ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles apparaissent plus fréquemment chez les enfants ou les personnes âgées." } }, { "@type": "Question", "name": "Les maladies auto-immunes sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque de troubles liés aux sphingolipides." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque." } }, { "@type": "Question", "name": "Les infections peuvent-elles aggraver les troubles des sphingolipides ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent exacerber les symptômes et les complications." } } ] } ] }

Sous-catégories

17 au total
└─

Glycosphingolipides

Glycosphingolipids D006028 - D10.570.877.360
└─└─

Glycosphingolipides acides

Acidic Glycosphingolipids D020384 - D10.570.877.360.025
└─└─

Glycosphingolipides neutres

Neutral Glycosphingolipids D020383 - D10.570.877.360.612
└─└─

Psychosine

Psychosine D011609 - D10.570.877.360.806
└─└─└─

Gangliosides

Gangliosides D005732 - D10.570.877.360.025.475
└─└─└─

Sulfoglycosphingolipides

Sulfoglycosphingolipids D013433 - D10.570.877.360.025.837
└─└─└─

Céramides

Ceramides D002518 - D10.570.877.360.612.200
└─└─└─

Sphingomyéline

Sphingomyelins D013109 - D10.570.877.360.612.870
└─└─└─└─

Ganglioside GM1

G(M1) Ganglioside D005677 - D10.570.877.360.025.475.390
└─└─└─└─

Ganglioside GM2

G(M2) Ganglioside D005678 - D10.570.877.360.025.475.400
└─└─└─└─

Ganglioside GM3

G(M3) Ganglioside D005679 - D10.570.877.360.025.475.510
└─└─└─└─

Cérébrosides

Cerebrosides D002554 - D10.570.877.360.612.200.250
└─└─└─└─

Globosides

Globosides D005915 - D10.570.877.360.612.200.425
└─└─└─└─

Lactosylcéramides

Lactosylceramides D007790 - D10.570.877.360.612.200.612
└─└─└─└─

Trihexosylcéramide

Trihexosylceramides D014281 - D10.570.877.360.612.200.906
└─└─└─└─└─

Galactosylcéramides

Galactosylceramides D005699 - D10.570.877.360.612.200.250.450
└─└─└─└─└─

Glucosylcéramides

Glucosylceramides D005963 - D10.570.877.360.612.200.250.490

Sources (10000 au total)

Service Demand for and Awareness of a Primary Healthcare Pilot Project for People With Disabilities.

This study investigated the demand for and awareness of a primary healthcare pilot project for people with disabilities; it also sought to identify relevant determinants for demand and awareness using... This study is a secondary analysis of data from the population-based survey conducted in Gyeonggi Regional Health & Medical Center for People with Disabilities. The data was designed with quota ra... Awareness of the service (12.1%) was remarkably low, while the demand (80.5%) was high. The gap between respondents who needed the service but were unaware of it differed according to age, education, ... Chronic disease and an unmet need for medical care were key determinants of service demand, while the severity of disability was not. Thus, there is a need to review the initiative that defines servic...

[The KomMent study: a pilot project on structured interprofessional communication in uro-oncology].

Communication and interprofessional collaboration with patients diagnosed with cancer is challenging. Structured communication training has not yet been integrated into postgraduate medical education.... A needs assessment was conducted using focus groups and individual interviews. Learning objectives were aligned with (inter)national learning objective catalogs. The ICT was developed using the six-st... Physician participation rates in the workshops were 83.0% and nursing participation rates were 58.3%. Utilization of the workplace-based training was 97%. The physicians evaluated the ICT very positiv... The implementation of an ICT with 80 teaching units is successfully feasible in a urological clinic and leads to a sustainable improvement of the communication culture, among other things through ment...

[Psychiatric-Psychotherapeutic Care in Crisis: Results of the LeiP#Netz Pilot Project].

Analysis of psychiatric-psychotherapeutic crisis services in the Leipzig Psychiatry Network (LeiP#netz), assigning the services to the functional areas of the FBM according to Steinhart and Wienberg.... A standardized survey of crisis care was conducted using the functions "complex outpatient treatment", "access to acute psychotherapy in crisis", and "24 h complex, intensive treatment" by means of fa... A total of 31 measures were recorded for the three functions. All crisis care services were highly utilized; in up to one-third of cases, no services could be provided when demand was requested. Servi... Crisis care services for severely mentally ill people are available in various constellations in the study region. Low-threshold 24/7 crisis services need to be expanded....

Adaptation of Screening Tools for Social Determinants of Health in Pregnancy: A Pilot Project.

Social determinants of health (SDOH) and stress during pregnancy may contribute to adverse pregnancy outcomes. The objective of this in the field pilot project was to develop a comprehensive screening... Pregnant patients accessing prenatal care at a single site of an urban Federally Qualified Health Center were recruited during prenatal visits to complete a Social Determinants of Health in Pregnancy ... Between April 2018 and March 2019, 135 pregnant participants completed SIPT. Ninety-one percent of patients scored positive on at least one screener, 54% to three or more screeners.... Despite guidelines to screen for SDOH during pregnancy there is no universal tool. Our pilot project demonstrated the concurrent use of adapted screening tools where participants reported at least one...

Colorectal Cancer Screening Pilot Project in Tehran-Iran, a Feasibility Study.

Colorectal cancer (CRC) is the third most common cancer in Iran, where there is no organised CRC-screening programme. This study aimed to evaluate feasibility of CRC screening using a qualitative feca... In this feasibility study, 7039 individuals aged 50-75 years were invited by community health workers (CHWs) in southern Tehran and its suburban districts between April 2018 and November 2019. The CHW... Acceptance rate at initial invitation was 71.7%. From 4974 average-risk adults (1600 males and 3374 females) who were offered FIT, 96.8% (n=4813) provided valid samples, of whom 471 (9.8%) tested posi... Our results partially support the feasibility of scaling up organized CRC-screening through the existing healthcare system in Iran; it remains to be discussed carefully to ensure the capacity of healt...

Conducting two evidence syntheses in six weeks - experiences with and evaluation of a pilot project.

Evidence synthesis organisations are trying to meet commissioners' needs for rapid responses to their evidence synthesis commissions. In this project we piloted an intensive process, working to comple... In a pre-planning phase, an intensive work group was established, and two commissions were selected for this pilot project. The evidence synthesis process was divided into two phases: planning and int... During the planning phase, teams identified significant uncertainties regarding scopes, research questions, and inclusion criteria. To address this, they engaged with commissioners earlier than origin... Overall, the intensive process fostered focus and productivity, allowing teams to manage short-term deliverables effectively. The researchers preferred working intensively with one evidence synthesis ...

[Implementation of a Pilot Project Supporting Parents Suffering from Cancer with Underage Children].

Families with one parent suffering from cancer are exposed to extraordinary emotional and organizational burdens, affecting underaged children. To help coordinated access to social and logistic suppor... A cross-sectional observational study was conducted using a mixed-method approach. Semi-structured written expert surveys (n=10) and secondary analysis of routine data of the care model (n=171 familie... Quantitative secondary analysis: The participating families had 1-7 children (median (m) 2, range (s) 6). In 66% of the cases, the mother was affected by cancer, in 20% the diseased parent was in a si... The data collected indicate that in families, matching the German average in their socio-demographic characteristics, a great need for organizational support develops as soon as one parent becomes sic...

A pilot project of expert nurses for the follow-up of complex intravenous antimicrobial treatment.

To report a pilot project of expert nurses for outpatient parenteral antimicrobial treatment (OPAT) follow-up.... Three nurses with specific training on antibiotics started a state-funded programme including: i) consultations for OPAT follow-up; ii) hotline for satellite hospitals; iii) peer training. Patients' d... From December 2020 to December 2021, 118 patients (median age 66.5 years [52-75], male-to-female ratio 2.5) were enrolled, for a total of 621 consultations. Patients were mostly on OPAT for bone and j... Nurses may be important actors for OPAT follow-up....

Implementation of entrustable professional activities into fellowship council accredited programs: a pilot project.

The Fellowship Council (FC) is transitioning to a competency-based medical education (CBME) model, including the introduction of Entrustable Professional Activities (EPAs) for training and assessment ... The FC coordinated the development of EPAs in collaboration with the sponsoring societies for Advanced GI/MIS, Bariatrics, Foregut, Endoscopy and Hepatopancreaticobiliary (HPB) fellowships encompassin... The 15 participating programs included 18 fellows and 106 faculty. A total of 655 assessments were initiated with 429 (65%) completed. The average (SD) number of EPAs completed for each fellow was 24(... A competency-based assessment framework was developed by the FC and piloted in several programs. Participation was variable and required ongoing strategies to address barriers. The pilot project has p...